Cardinal Health Inc (CAH)

NYSE
Currency in USD
139.84
+1.60(+1.16%)
Closed·
After Hours
138.24-1.60(-1.14%)
·
CAH Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected tomorrow
Fair Value
Day's Range
137.35140.50
52 wk Range
93.17140.50
Key Statistics
Edit
Prev. Close
138.24
Open
138.24
Day's Range
137.35-140.5
52 wk Range
93.17-140.5
Volume
2.1M
Average Vol. (3m)
2.63M
1-Year Change
35.89%
Book Value / Share
-12.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
143.07
Upside
+2.31%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Cardinal Health Inc Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Employees
48411

Cardinal Health Inc SWOT Analysis


Future Outlook
Analyst price targets range from $107 to $140, reflecting varied perspectives on Cardinal Health's growth potential and strategic initiatives
Market Positioning
Explore Cardinal Health's valuation gap compared to competitors, with analysts noting potential for multiple expansion from its current 14x CY2025 EPS
Strategic Expansion
Delve into Cardinal Health's $1.115 billion acquisition of ION, signaling a shift from defensive to offensive strategies in the oncology market
Financial Resilience
Cardinal Health surpasses expectations with robust Q1 FY2025 results, raising EPS guidance and projecting strong growth despite industry challenges
Read full SWOT analysis

Cardinal Health Inc Earnings Call Summary for Q2/2025

  • Q2 2024 EPS of $1.93 beat $1.77 forecast; revenue of $55.3B exceeded $54.56B projection; stock dipped 1.61% pre-market
  • Full-year EPS guidance raised to $7.85-$8.00; pharma segment profit up 7% YoY to $531M despite 4% revenue decline
  • Specialty distribution shows strong growth; company investing in automation and domestic manufacturing to mitigate supply chain risks
  • CEO Jason Holler: Q2 results reflect strategy acceleration and execution precision; CFO Alt highlights specialty distribution performance
  • Challenges include supply chain complexities, market saturation, economic uncertainties, and potential regulatory changes in healthcare
Last Updated: 01/31/2025, 12:00 PM
Read Full Transcript

Compare CAH to Peers and Sector

Metrics to compare
CAH
Peers
Sector
Relationship
P/E Ratio
25.7x−1.2x−0.5x
PEG Ratio
0.280.060.00
Price / Book
−11.3x0.7x2.6x
Price / LTM Sales
0.2x0.6x2.9x
Upside (Analyst Target)
8.5%121.9%56.4%
Fair Value Upside
Unlock24.5%9.3%Unlock

Analyst Ratings

11 Buy
5 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 143.07
(+2.31% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.41%
Dividend Yield
1.46%
Industry Median 1.73%
Annualized Payout
2.02
Paid quarterly
5-Years Growth
+1.00%
Growth Streak

Earnings

Latest Release
Jan 30, 2025
EPS / Forecast
1.93 / 1.77
Revenue / Forecast
55.30B / 54.56B
EPS Revisions
Last 90 days

People Also Watch

144.55
KEYS
+0.42%
319.82
ANSS
+0.57%
371.19
GEV
+0.31%
25.31
YOU
+1.00%
290.17
COR
+0.84%

FAQ

What Is the Cardinal Health (CAH) Stock Price Today?

The Cardinal Health stock price today is 139.84

What Stock Exchange Does Cardinal Health Trade On?

Cardinal Health is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Cardinal Health?

The stock symbol for Cardinal Health is "CAH."

Does Cardinal Health Pay Dividends? What’s The Current Dividend Yield?

The Cardinal Health dividend yield is 1.45%.

What Is the Cardinal Health Market Cap?

As of today, Cardinal Health market cap is 33.81B.

What is Cardinal Health Earnings Per Share?

The Cardinal Health EPS is 5.41.

What Is the Next Cardinal Health Earnings Date?

Cardinal Health will release its next earnings report on May 01, 2025.

From a Technical Analysis Perspective, Is CAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.